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Abstract  
BACKGROUND: Acetaminophen is a drug widely used in children because of its safety and 
efficacy. Although the risk of its toxicity is lower in children such reactions occur in pediatric patients 
from intentional overdoses and less frequently attributable to unintended inappropriate dosing. The 
aim of reporting this case is to attract the attention to the risk of the acetaminophen toxicity when 
administered in high doses. 
CASE PRESENTATION: We report here a 5 year old girl who developed fulminate liver failure with 
renal impairment and acute pancreatitis, as a result of acetaminophen toxicity caused from 
unintentional repeated supratherapeutic ingestion, with a total administered dose of 4800 mg in 
three consecutive days, 1600 mg/day, approximately 90 mg/kg/day. The blood level of 
acetaminophen after 10 hours of the last administered dose was 32 mg/l. The patient presented 
with high fever, jaundice, lethargic, agitating with abdominal pain accompanied by encephalopathy. 
The liver function test revealed with high level of alanine aminotransferase 5794 UI/l and aspartate 
aminotransferase 6000 UI/l. Early initiation of oral N-acetylcysteine (NAC) after biochemical 
evidence of liver toxicity was beneficial with rapid improvement of liver enzymes, hepatic function 
and encephalopathy. During the course of the illness the child developed acute pancreatitis with 
hyperamylasemia 255 UI/L and hyperlypasemia 514 UI/ L. Patient totally recovered within 29 days. 
CONCLUSION: Healthcare providers should considered probable acetaminophen toxicity in any 
child who has received the drug and presented with liver failure. When there is a high index of 
suspicion of acetaminophen toxicity NAC should be initiated and continued until there are no signs 
of hepatic dysfunction. 
 
 
 
 
Introduction 
 
Acetaminophen is the most widely used 
analgesic and antipyretic drug in infants and children. 
The safety of acetaminophen is well established 
especially in comparison with aspirin. Therefore it is 
used over the counter and on prescription. The 
recommended maximum therapeutic dosage in 
symptomatic fever and analgesia in children is 50 to 
75 mg/kg/d [1]. 
Acetaminophen poisoning remains one of the 
more common drugs taken in overdose with 
potentially fatal consequences. A single acute 
ingestion of greater than 7.5 g in an adult or 150 
mg/kg in children has been considered potentially 
toxic [2]. In the United Kingdom, nearly 50% of drug 
poisoning was due to it and the mortality was about 
100 to 200 victims per year. Reviewing database in 
the Toxic Exposure Surveillance System of the 
American Association of Poisson Control in 2004, 19 
590 cases were under the age of six [3]. 
In general the risk of developing toxic 
reactions appears to be lower in children than in 
adults [4]. The most common organ affected by 
acetaminophen intoxication is the liver when 
administered in supratherapeutic doses or repeated 
therapeutic doses can also be toxic [4, 5]. Because 
the symptoms of acetaminophen intoxication are 
nonspecific the diagnosis and the treatment are more 
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likely to be delayed in such cases. The health care 
providers should consider acetaminophen toxicity as a 
probable diagnosis in any child who has received the 
drug and has sign of hepatic failure. Early initiation of 
NAC is indicated whenever the acetaminophen is 
considered, as the delays in the treatment are 
associated with a worse outcome [4].
 
The aim of this report is to present fulminate 
hepatic failure in a 5 year old female after 
inappropriate acetaminophen treatment. 
 
 
Case Report 
 
Day 1 
The 5 year old female child enjoyed good 
health in the past until three days before the 
admission when she began to have high fever, 
vomiting and diarrhea. The child was treated by the 
mother with different formulation of acetaminophen as 
suppositories 250 mg and tablets 500 mg every 3 
hours for three consecutive days. The used dose of 
acetaminophen was calculated by the physician at the 
admission time to Pediatric Intensive Care Unit of 
UHC, being approximately 90 mg/kg/24h for the last 
72 hours. No other concomitant medication was 
administered.  
At the admission the child presented with high 
fever, vomiting, confusion, drowsiness alternated with 
agitation especially to external stimuli. On 
examination, absent neck stiffness, Babinski response 
was negative, pupils were slightly midriatic, corneal 
reflex was present, sensible only to pain according to 
AVPU evaluation and was classified as grade II to III 
of encephalopathy, dehydrated and icteric. The 
arterial pressure was 90/50 mmHg, heart rate was 
160/ min, the respiratory rate was 45/min the 
temperature was 39
o
C, the pulsoximeter 97% 
saturation in room air. Abdominal palpation revealed 
liver enlargement 2-3 cm under the costal arch, and a 
soft palpable abdomen. The bedside blood sugar was 
45 mg/dl, ALT 5794 UI/L, AST 6000 UI/L, Total 
Bilirubine 3.5 mg/dl, INR 3.86, blood urea 80 mg/dl, 
blood creatinine 1.3 mg/dl, ȢGT 60 UI/l, Na+ 111 
mmol/l, K+3.5 mmol/l. The blood albumin level 3 g/dl, 
Red blood cells 4.4*10
12
/L, Hemoglobine 12.3 g/dl, 
Platelets 332*10
9
/L, White blood cell 25*10
9
/L C 
reactive Protein 70 mg/dl. A careful disease history 
was taken and acetaminophen poisoning was strongly 
suspected. The blood acetaminophen obtained 10 
hours after the last administered dose, was sent 
abroad having the positive result 32.9 mg/l. The viral 
serologic profile includes HIV, HEV, HAV, HCV, HBV, 
Coksaxie Virus, influenza A, B, Adeno Virus, was 
negative. The chest radiograph was normal. Blood 
culture failed to isolate any microorganism. NAC was 
immediately given by nasogastric tube as the only 
drug formulation the hospital could provide according 
to the standard oral guideline with 140 mg/kg loading 
dose followed by 70 mg/kg every 4 hours for a total of 
18 doses over 72 hours. Oral feeding was stopped 
and the hydration was maintained by electrolytic 
solution.  
Table 1: Serial Laboratory Investigations in our patient 
Investigation  Day 1 Day 2 Day 3   Day 5 
Hb (g/dl)  12.3  9.5   
Total white counts/L 25*10
9
 
 
22*10
9  
 
Platelets/L  332*10
9  
444*10
9  
 
Albumin (g/dl) 3 3.2 4.4 4.4 
Bilirubin (mg/dl) 3.5 2.5 1.4 0.5 
ALT (U/L)  5794 3250 570 58 
AST (U/L)   6000 2900 490 95 
GGT (U/L)  60    
Amylase (U/L)   255 43 
Lypase  (U/L)   514 
Creatinine (mg/dl) 1.3 1.1 0.98 0.45 
Urea (mg/dl)  80 50 43 10.3 
Blood sugar (mg/dl) 45 90 340 110 
Acetaminophen (mg/L) 32.9 
INR  3.86 3.14 2.13 
C reactive protein (mg/dl) 70   100 
Hb: haemoglobin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: 
gamma glutamyltranspeptidase; INR: international normalised ratio. 
 
 
Day 2-5  
After administration of 18 oral recommended 
NAC doses of hepatic failure treatment protocol, the 
renal indicators as blood creatinine, blood urea and 
the liver enzymes were improved but without INR. The 
coagulopathy aggravated with clinical manifestations 
of melena and hematemesis despite the therapy with 
fresh frozen plasma, Vitamin K, Human Albumin, Acid 
tranexamic, Lactulose. Abdomen became painful and 
the blood sugar 340 mg/dl, hypernatremia 160 meq/l, 
hypokalemia 2.7 meq/l. Acute pancreatitis was 
suspected and confirmed by hyperamylasaemia 255 
UI/l, hyperlypasaemia 514 UI/l, and ultrasound 
examination which revealed a swollen pancreas and 
minimal peritoneal liquid at Douglas space. 
Accordingly the therapy was modified to parenteral 
hydration, fluid and electrolytes correction and 
reduces enteral stimulation. A further 24 hours of NCA 
treatment was added until the INR and pancreatic 
enzyme decline. 
 
Day 7 
As the patient condition improved in terms of 
hepatic failure and clinical acute pancreatitis, the fever 
remained high with chills and high spikes. The patient 
developed left leg pain with thrombophlebitis and 
coccygofemoral arthritis.  
The repeated blood culture finally isolated 
Klebsiella pneumoniae despite the extendum 
spectrum antibiotics (Cefuroxime 150 mg/kg/day and 
gentamicin 5 mg/kg/day) and the therapy was adopted 
according to antibiotic susceptibility (Piperacillin-
Tazobactam and Amikacin) supported with 
Pentaglobine. This situation required also the use of 
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anticoagulant (Fraxiparin 2850 UI s/c) and Ibuprofen. 
Despite the long progress of the disease the child 
recovered totally within 29 days with a complete 
resolution of all clinical and laboratory abnormalities. 
The liver function tests remained in normal range 
during the following up of 1st, 3rd, 6th and 12th 
month. 
 
 
Discussion 
In Albania acetaminophen toxicity in children 
is uncommon. Many parents use this medication 
without consulting doctors. The aim of reporting this 
case was to attract the attention to the risk of the 
acetaminophen toxicity when administered in high 
doses. 
When it happens acetaminophen-induced 
hepatotoxicity remains a serious condition in pediatric 
practice [6]. Cases of acetaminophen toxicity induced 
by multiple therapeutic or supratherapeutic doses 
have been reported [7]. Recent reviews identified 
several factors associated with acetaminophen 
hepatotoxicity and other extra-hepatic manifestations 
in children including: age less than 10 years, delays in 
onset of symptoms after a potentially toxic ingestion, 
delay in initiation of NAC treatment, unintentional 
multiple overdosing, ingestion of acetaminophen with 
other hepatotoxic drugs and the use of adult rather 
than pediatric preparations [4].  
In the reported case the hepatic failure was 
caused by using unintentionally repeated excessive 
dosing of acetaminophen as pediatric preparation in 
suppositories 250 mg combined with adults 
preparations in tablet of 500 mg, every 3 hours for 
three consecutive days. The calculated dose of the 
used acetaminophen in our case was approximately 
90 mg/kg/24h for more than 72 hours which almost 
compiles with the recent expert panel’s guideline in 
management of acetaminophen RSTI (repeated 
supratherapeutic ingestion). According to this panel’s 
guideline, doses 100 mg/kg or more per 24 hours for 
72 hours or more, are doses of concern for liver injury 
in children younger than 6 years [8]. Lower doses in 
sick children younger than 2 years in presence of risk 
factors such as febrile illness, prolonged starvation, 
diarrhea, repeated vomiting and poor fluid intake more 
than 24 h may suffice to cause hepatotoxicity [9]. 
Acetaminophen is metabolized in the liver via 3 main 
pathways: sulfation, glucuronidation and oxidation. 
The first 2 ways are quantitatively more important, but 
oxidative pathway is implicated in toxicity. The sulfate 
pathway may become depleted during repeated 
multiple doses of actaminophen which result in 
hepatotoxicity because the drug is oxidized by CYP 
(CYP2 E1, 3A4, and 1A2) to the toxic metabolite (N-
acetyl-p-benzoquinone imine{NAPQI}) that is 
detoxified by glutathione. In overdose cases 
glutathione declines and the toxic NAPQI fraction 
produces hepatic necrosis [10].
 
Many reported cases 
of severe hepatoxicity in children have been attributed 
to cumulative toxicity from repeated doses rather than 
acute intoxication from a single massive overdose [4]. 
In our case the serum level of acetaminophen was 
performed abroad and the result came late while the 
diagnosis was concluded based on clinical 
presentation and the medical history. In fact the 
assessment of serum acetaminophen levels is useful 
in the management of the overdose when the time of 
ingestion is known with certainty. In such cases the 
Rumack-Mathews nomogram is a valuable tool to 
assess the risk of hepatotoxicity. However, if the 
overdose is staggered over a long period, serum 
acetominophen tests are impossible to be interpreted 
by this nomogram [2]. The symptoms of 
acetaminophen intoxication are nonspecific, making 
diagnosis and treatment of unintentional 
acetaminophen intoxication more likely to be delayed 
[11], as it happened in our case. While the 
acetaminophen poisoning has primarily been 
associated with hepatoxicity, a range of less common 
extrahepatic manifestations has also been described. 
Among these, nephropathy has been recognized as a 
clinically important complication and considerable 
prognostic implications [12]. In the current case the 
renal involvement was present at the admission time 
and renal indicators improved rapidly along the 
therapy. Pancreatitis, cardiotoxicity and hematotoxicity 
are the more unusual complication of acetaminophen 
poisoning. During the disease course, the clinical and 
laboratory diagnosis of pancreatitis was made based 
on hyperlypasaemia, hyperamylasaemia level, 
hyperglycemia and changes on abdomen 
ultasonography. Acute pancreatitis has been 
described between 6 and 41% of patients with 
fulminant hepatic failure FHF. Although 
hyperamylasemia is a common finding in patients with 
acetaminophen poisoning, clinical signs of pancreatitis 
are rare only a few cases of acetaminophen induced 
pancreatitis have been reported. In one study 
performed in Denmark hyperamylasaemia occurred in 
80% acetaminophen induced-FHF while only 13 % 
was diagnosed with clinical pancreatitis and only two 
cases with actetaminophen – induced pancreatitis 
without liver and kidney involvement [12]. In the 
current case diagnosis of pancreatitis was suspected 
and confirmed by the third day. N-acetylcysteine NAC 
is an effective antidote for acetaminophen poisoning. 
When administered early dramatically reduces the 
incidence of hepatotoxicity and the FHF. NAC 
provides cysteine for the replenishment and 
maintenance of hepatic glutathione stores enhances 
the sulfation pathway of elimination or directly reduces 
NAPQI back to acetaminophen. Patients with severe 
hepatic injury also benefit from NAC. The mechanism 
here is not the detoxification of NAPQI but the 
enhanced recovery through improvement of hepatic 
perfusion and oxygen delivery and extraction, 
mitochondrial energy production, scavenge of reactive 
oxygen and nitrogen. NAC is available both orally and 
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intravenously. Both regimes are effective for the 
treatment of an acute acetaminophen overdose. 
Whatever the route of administration following an 
acute acetaminophen ingestion, the treatment should 
not be delayed beyond 8 hours. Conversely in 
patients with hepatotoxicity NAC should be continued 
beyond the usual course of therapy in any patients 
with persistent signs of liver injury [2].
 
In the current 
case the effectiveness was evident with the first 18 
oral doses in terms of dramatic decline in liver 
enzymes while the INR improvement and pancreatic 
enzymes decline came after an additional 24 hours of 
NAC administration. We consider the decision to 
continue the oral NAC beyond the usual course 
reasonable. 
In conclusion, although acetaminophen is 
considered a safe drug in children it has the potential 
for hepatoxicity not only in intentional overdoses but 
even with unintended inappropriate doses. Healthcare 
providers should considered probable acetaminophen 
toxicity in any child who has received the drug and 
presented with liver failure. When there is a high index 
of suspicion of acetaminophen toxicity NAC should be 
initiated and continued until there are no signs of 
hepatic dysfunction. 
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